Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
news_6

China Recombinant Human Thrombopoietin Markets, 2015-2020 & 2021-2025 – In 2019, the Market Reached CNY 1257 Million, Representing a CAGR of 40.9% from 2015 to 2019 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Recombinant Human Thrombopoietin Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering. In recent...

news_6

China Automobile Tire Industry Report 2021-2025: Driving Forces and Market Opportunities, Impact of COVID-19, Threats and Challenges – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Research Report on the Automobile Tire Industry in China, 2021-2025" report has been added to ResearchAndMarkets.com's offering. China...

news_6

APAC Data Center Market Industry Outlook and Forecast 2021-2026 – Artificial Intelligence Enhances Liquid Immersion & Direct-to-Chip Cooling Adoption – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "APAC Data Center Market - Industry Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The...

news_6

HKTB to Boost the City’s Recovery Through New “Hong Kong Super Fans” Global Engagement Programme With Hundreds of Participants From 20 Key Markets

HONG KONG--(BUSINESS WIRE)--The Hong Kong Tourism Board (HKTB) announced today its first global fan-engagement programme, “Hong Kong Super Fans”, to...

news_6

Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease

Takeda Applies for Approval for the Company’s First Allogeneic Stem Cell Therapy in Japan If Approved, Darvadstrocel Would Offer a...

news_6

Moderna Announces COVID-19 Vaccine Supply Agreements with the Government of Taiwan for 5 Million Doses and the Government of Colombia for 10 Million Doses

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two supply...